Primaquine Phosphate (sanofi-aventis U.S. LLC)
Welcome to the PulseAid listing for the Primaquine Phosphate drug offered from sanofi-aventis U.S. LLC. This Antimalarial [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | sanofi-aventis U.S. LLC |
| NON-PROPRIETARY NAME: | Primaquine Phosphate |
| SUBSTANCE NAME: | PRIMAQUINE PHOSPHATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antimalarial [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-04-15 |
| END MARKETING DATE: | 0000-00-00 |
Primaquine Phosphate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Primaquine Phosphate from sanofi-aventis U.S. LLC |
| LABELER NAME: | sanofi-aventis U.S. LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15(mg/1) |
| START MARKETING DATE: | 2011-04-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0024-1596_e98f9e68-e83d-43f1-8add-a0b9cc5614b9 |
| PRODUCT NDC: | 0024-1596 |
| APPLICATION NUMBER: | NDA008316 |
Other PRIMAQUINE PHOSPHATE Pharmaceutical Manufacturers / Labelers:
